Search

Search Constraints

You searched for: Author/Creator Lehrke, Michael

Search Results

3. Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: Data from a randomized, placebo‐controlled study. Issue 12 (25th August 2021)

4. Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study. (August 2021)

5. Empagliflozin Improves Left Atrial Strain in Patients With Type 2 Diabetes: Data From a Randomized, Placebo-Controlled Study. (12th April 2023)

6. Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure. (25th May 2022)

8. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction. (16th October 2019)

10. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology. (8th October 2018)